UK Markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.51+0.94 (+2.26%)
At close: 04:00PM EDT
43.00 +0.49 (+1.15%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.22
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3138.52
52-week low 327.77
50-day moving average 337.28
200-day moving average 367.06

Share statistics

Avg vol (3-month) 31.36M
Avg vol (10-day) 31.86M
Shares outstanding 568.14M
Implied shares outstanding 6N/A
Float 857.21M
% held by insiders 11.99%
% held by institutions 177.22%
Shares short (28 Apr 2022) 410.81M
Short ratio (28 Apr 2022) 49.48
Short % of float (28 Apr 2022) 417.75%
Short % of shares outstanding (28 Apr 2022) 415.41%
Shares short (prior month 30 Mar 2022) 48.82M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-458.13%

Management effectiveness

Return on assets (ttm)-15.41%
Return on equity (ttm)-69.13%

Income statement

Revenue (ttm)51.84M
Revenue per share (ttm)0.81
Quarterly revenue growth (yoy)851,050.00%
Gross profit (ttm)51.84M
EBITDA -230.06M
Net income avi to common (ttm)-370.64M
Diluted EPS (ttm)-6.54
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)965.65M
Total cash per share (mrq)14.28
Total debt (mrq)147.64M
Total debt/equity (mrq)17.86
Current ratio (mrq)5.96
Book value per share (mrq)12.85

Cash flow statement

Operating cash flow (ttm)-66.27M
Levered free cash flow (ttm)-346.41M